Miltenyi Biotec B.V. & Co. KG
3 clinical trials · Sponsor
◉ Watch Miltenyi Biotec B.V. & Co. KG
| Record | Firm | Date |
|---|---|---|
| CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR (NCT03152526) | Miltenyi Biotec B.V. & Co. KG | 2017-10-18 |
Track Miltenyi Biotec B.V. & Co. KG automatically
Every clearance here is in the API, with alerts when new ones post.